Functionalised multi-walled carbon nanotubes (MWCNTs) are exclusively used in antibacterial activity due to their high aspect ratio and surface penetration characteristics. This study reports the synthesis of piperazine and dopamine functionalised MWCNTs to investigate antibacterial activity against strains like Staphylococcus aureus and Micrococcus luteus. MWCNTs were activated through acid oxidation and then refluxed at 75°C for 10 and 8 h in the presence of piperazine and dopamine, respectively. The functionalised MWCNTs were characterised by scanning electron microscopy, Fourier-transform infrared spectroscopy, X-ray diffraction and Raman spectroscopy. Moreover, functionalised MWCNTs were subjected to zone inhibition assay on agar plates. Results revealed the significant antibacterial activity against various bacteria up to 50%. Similarly, it was observed that the effect of different solvents, such as dimethyl formamide (DMF) and dimethyl sulfoxide (DMSO) was non-prevalent to the bacterial zone of inhibition. Such facile nano-modifications provide passage to nano-antibacterials for advanced studies.

References

1. 1)
  - 27. Suryavanshi, H.R.: ‘Synthesis and biological activities of piperazine derivatives as antimicrobial and antifungal agents’, Organic Commun., 2017, 10, p. 228 (doi: 10.25135/acg.oc.23.17.05.026).
2. 2)
  - 21. Katz, E., Willner, I.: ‘Biomolecule-functionalized carbon nanotubes: applications in nanobioelectronics’, ChemPhysChem, 2004, 5, pp. 1084–1104 (doi: 10.1002/cphc.200400193).
3. 3)
  - 7. Nel, A., Xia, T., Mädler, L., et al: ‘Toxic potential of materials at the nanolevel’, Science, 2006, 311, pp. 622–627 (doi: 10.1126/science.1114397).
4. 4)
  - 14. Kerns, R.J., Rybak, R.J., Kaatz, G.W., et al: ‘Structural features of piperazinyl-linked ciprofloxacin dimers required for activity against drug-resistant strains of Staphylococcus aureus’, Bioorg. Med. Chem. Lett., 2003, 13, pp. 2109–2112 (doi: 10.1016/S0960-894X(03)00376-7).
5. 5)
  - 29. Khashan, K.S., Jabir, M.S., Abdulameer, F.A.: ‘Carbon nanoparticles prepared by laser ablation in liquid environment’, Surf. Rev. Lett., 2019, 26, p. 1950078 (doi: 10.1142/S0218625X19500781).
6. 6)
  - 30. Khashan, K.S., Jabir, M.S., Abdulameer, F.A.: ‘Carbon nanoparticles decorated with cupric oxide nanoparticles prepared by laser ablation in liquid as an antibacterial therapeutic agent’, Mater. Res. Express, 2018, 5, p. 035003 (doi: 10.1088/2053-1591/aab0ed).
7. 7)
  - 39. Abuilaiwi, F.A., Laoui, T., Al-Harthi, M., et al: ‘Modification and functionalization of multiwalled carbon nanotube (MWCNT) via Fischer esterification’, Arabian J. for Sci. Eng., 2010, 35, pp. 37–48.
8. 8)
  - 35. Chen, Y., Guo, L.-R., Chen, W., et al: ‘3-mercaptopropylphosphonic acid modified gold electrode for electrochemical detection of dopamine’, Bioelectrochemistry, 2009, 75, pp. 26–31 (doi: 10.1016/j.bioelechem.2008.12.005).
9. 9)
  - 20. Zhang, Y., Li, J., Shen, Y., et al: ‘Poly-L-lysine functionalization of single-walled carbon nanotubes’, J. Phys. Chem. B, 2004, 108, pp. 15343–15346 (doi: 10.1021/jp0471094).
10. 10)
  - 5. Lam, C. -W., James, J.T., McCluskey, R., et al: ‘Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation’, Toxicol. Sci., 2004, 77, pp. 126–134 (doi: 10.1093/toxsci/kfg243).
11. 11)
  - 32. Khashan, K.S., Sulaiman, G.M., Mahdi, R.: ‘Preparation of iron oxide nanoparticles-decorated carbon nanotube using laser ablation in liquid and their antimicrobial activity’, Artif. cells, Nanomed. Biotechnol., 2017, 45, pp. 1699–1709 (doi: 10.1080/21691401.2017.1282498).
12. 12)
  - 17. Tran, P.A., Zhang, L., Webster, T.J.: ‘Carbon nanofibers and carbon nanotubes in regenerative medicine’, Adv. Drug Delivery Rev., 2009, 61, pp. 1097–1114 (doi: 10.1016/j.addr.2009.07.010).
13. 13)
  - 38. Jabir, N.R., Tabrez, S., Ashraf, G.M., et al: ‘Nanotechnology-based approaches in anticancer research’, Int. J. Nanomed., 2012, 7, p.4391.
14. 14)
  - 22. Tejral, G., Panyala, N.R., Havel, J., ‘Carbon nanotubes: toxicological impact on human health and environment’, J. Appl. Biomed., 2009, 7, pp. 1–13 (doi: 10.32725/jab.2009.001).
15. 15)
  - 40. Abdalla, M., Dean, D., Robinson, P., et al: ‘Cure behavior of epoxy/MWCNT nanocomposites: the effect of nanotube surface modification’, Polymer, 2008, 49, pp. 3310–3317 (doi: 10.1016/j.polymer.2008.05.016).
16. 16)
  - 26. Waszkielewicz, A., Gunia, A., Szkaradek, N., et al: ‘Synthesis and evaluation of pharmacological properties of some new xanthone derivatives with piperazine moiety’, Bioorg. Med. Chem. Lett., 2013, 23, pp. 4419–4423 (doi: 10.1016/j.bmcl.2013.05.062).
17. 17)
  - 37. Mailman, R. B., Nichols, D. E., Tropsha, A.: ‘Molecular drug design and dopamine receptors’, In: Neve, K. A., Neve, R. L. [EDs]: ‘The dopamine receptors’ (Humana Press, Totowa, NJ, USA, 1997), pp. 105–133.
18. 18)
  - 48. Kar, P., Choudhury, A.: ‘Carboxylic acid functionalized multi-walled carbon nanotube doped polyaniline for chloroform sensors’, Sens. Actuators, B, 2013, 183, pp. 25–33 (doi: 10.1016/j.snb.2013.03.093).
19. 19)
  - 19. Hamwi, A., Alvergnat, H., Bonnamy, S., et al: ‘Fluorination of carbon nanotubes’, Carbon. N. Y., 1997, 35, pp. 723–728 (doi: 10.1016/S0008-6223(97)00013-4).
20. 20)
  - 41. Saleh, T.A.: ‘The influence of treatment temperature on the acidity of MWCNT oxidized by HNO3 or a mixture of HNO3/H2SO4’, Appl. Surf. Sci., 2011, 257, pp. 7746–7751 (doi: 10.1016/j.apsusc.2011.04.020).
21. 21)
  - 28. Khabnadideh, S., Rezaei, Z., Pakshir, K., et al: ‘Synthesis and antifungal activity of benzimidazole, benzotriazole and aminothiazole derivatives’, Res. Pharm. Sci., 2012, 7, p. 65.
22. 22)
  - 12. Ryge, T.S., Hansen, P.R.: ‘Novel lysine-peptoid hybrids with antibacterial properties’, J. Pept. Sci., 2005, 11, pp. 727–734 (doi: 10.1002/psc.705).
23. 23)
  - 16. Zaman, S., Hussain, S., Butt, F.K., et al: ‘Functionalization of carbon nanotubes by a facile chemical method and its application in anti-diabetic activity’, J. Nanosci. Nanotechnol., 2017, 17, pp. 8557–8561 (doi: 10.1166/jnn.2017.15178).
24. 24)
  - 44. Neelgund, G.M., Oki, A.: ‘Photocatalytic activity of Cds and Ag2S quantum dots deposited on poly (amidoamine) functionalized carbon nanotubes’, Appl. Catal., B, 2011, 110, pp. 99–107 (doi: 10.1016/j.apcatb.2011.08.031).
25. 25)
  - 11. Yan, L., Zhao, F., Li, S., et al: ‘Low-toxic and safe nanomaterials by surface-chemical design, carbon nanotubes, fullerenes, metallofullerenes, and graphenes’, Nanoscale, 2011, 3, pp. 362–382 (doi: 10.1039/C0NR00647E).
26. 26)
  - 1. Kang, S., Herzberg, M., Rodrigues, D.F., et al: ‘Antibacterial effects of carbon nanotubes: size does matter!’, Langmuir, 2008, 24, pp. 6409–6413 (doi: 10.1021/la800951v).
27. 27)
  - 31. Khashan, K.S., Sulaiman, G.M., Mahdi, R.: ‘The effect of laser energy on the properties of carbon nanotube – iron oxide nanoparticles composite prepared via pulsed laser ablation in liquid’, Mater. Res. Express, 2018, 5, p. 105004 (doi: 10.1088/2053-1591/aadabc).
28. 28)
  - 41. Jeong, J.-K., Gurunathan, S., Kang, M.-H., et al: ‘Hypoxia-mediated autophagic flux inhibits silver nanoparticle-triggered apoptosis in human lung cancer cells’, Sci. Rep., 2016, 6, (1), pp. 1–13 (doi: 10.1038/s41598-016-0001-8).
29. 29)
  - 45. Eklund, P., Holden, J., Jishi, R.: ‘Vibrational modes of carbon nanotubes; spectroscopy and theory’, Carbon, 1995, 33, pp. 959–972 (doi: 10.1016/0008-6223(95)00035-C).
30. 30)
  - 42. Vuković, G., Marinković, A., Obradović, M., et al: ‘Synthesis, characterization and cytotoxicity of surface amino-functionalized water-dispersible multi-walled carbon nanotubes’, Appl. Surf. Sci., 2009, 255, pp. 8067–8075 (doi: 10.1016/j.apsusc.2009.05.016).
31. 31)
  - 18. Chen, H., Wang, B., Gao, D., et al: ‘Broad-spectrum antibacterial activity of carbon nanotubes to human gut bacteria’, Small, 2013, 9, (16), pp. 2735–2746 (doi: 10.1002/smll.201202792).
32. 32)
  - 2. Chen, X., Tam, U.C., Czlapinski, J.L., et al: ‘Interfacing carbon nanotubes with living cells’, J. Am. Chem. Soc., 2006, 128, pp. 6292–6293 (doi: 10.1021/ja060276s).
33. 33)
  - 3. Donaldson, K., Stone, V., Tran, C., et al: ‘Nanotoxicology’, Occup. Environ. Med., 2004, 61, pp. 727–728 (doi: 10.1136/oem.2004.013243).
34. 34)
  - 8. Wick, P., Manser, P., Limbach, L. K., et al: ‘The degree and kind of agglomeration affect carbon nanotube cytotoxicity’, Toxicol. Lett., 2007, 168, pp. 121–131 (doi: 10.1016/j.toxlet.2006.08.019).
35. 35)
  - 9. Zhu, Y., Ran, T., Li, Y., et al: ‘Dependence of the cytotoxicity of multi-walled carbon nanotubes on the culture medium’, Nanotechnology, 2006, 17, p. 4668 (doi: 10.1088/0957-4484/17/18/024).
36. 36)
  - 47. Babenko, V.: ‘Tailoring the synthesis of graphene and other 2D materials towards applications’, in University of Oxford’, 2016.
37. 37)
  - 25. Hussain, S., Parveen, S., Hao, X., et al: ‘Structure–activity relationships studies of quinoxalinone derivatives as aldose reductase inhibitors’, Eur. J. Med. Chem., 2014, 80, pp. 383–392 (doi: 10.1016/j.ejmech.2014.04.047).
38. 38)
  - 6. Magrez, A., Kasas, S., Salicio, V., et al: ‘Cellular toxicity of carbon-based nanomaterials’, Nano Lett., 2006, 6, pp. 1121–1125 (doi: 10.1021/nl060162e).
39. 39)
  - 15. Upadhayaya, R.S., Sinha, N., Jain, S., et al: ‘Optically active antifungal azoles: synthesis and antifungal activity of (2R, 3S)-2-(2, 4-difluorophenyl)-3-(5-{2-[4-aryl-piperazin-1-yl]-ethyl}-tetrazol-2-yl/1-yl)-1-[1, 2, 4]-triazol-1-yl-butan-2-ol’, Bioorg. Med. Chem., 2004, 12, pp. 2225–2238 (doi: 10.1016/j.bmc.2004.02.014).
40. 40)
  - 13. Yang, Q.-Z., Wang, C., Lang, L., et al: ‘Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa’, Arch. Pharmacal Res., 2013, 36, pp. 1302–1310 (doi: 10.1007/s12272-013-0112-8).
41. 41)
  - 33. Khashan, K.S., Jabir, M.S., Abdulameer, F.A.: ‘Preparation and characterization of copper oxide nanoparticles decorated carbon nanoparticles using laser ablation in liquid’, J.f Phys.: Conf. Series, 2018, 1003, p. 12100.
42. 42)
  - 34. Mohsin, M.H.: ‘Carbon nanotube prepared by pulse laser ablation of graphite target in iso-propanol solution’, Eng. Technol. J., 2013, 31, pp. 3078–3089.
43. 43)
  - 24. Singh, K.K., Joshi, S.C., Mathela, C.S.: ‘Synthesis and in vitro antibacterial activity of N-alkyl and N-aryl piperazine derivatives’, Indian J. Chem. Section B, 2011, 50, (2), pp. 196–200.
44. 44)
  - 46. Lee, Y.S., Cho, T.H., Lee, B.K., et al: ‘Surface properties of fluorinated single-walled carbon nanotubes’, J. Fluorine Chem., 2003, 120, pp. 99–104 (doi: 10.1016/S0022-1139(02)00316-0).
45. 45)
  - 10. Zardini, H.Z., Amiri, A., Shanbedi, M., et al: ‘Enhanced antibacterial activity of amino acids-functionalized multi walled carbon nanotubes by a simple method’, Colloids Surf. B, Biointerfaces, 2012, 92, pp. 196–202 (doi: 10.1016/j.colsurfb.2011.11.045).
46. 46)
  - 36. Zhou, C.H., Wang, Y.: ‘Recent researches in triazole compounds as medicinal drugs’, Curr. Med. Chem., 2012, 19, pp. 239–280 (doi: 10.2174/092986712803414213).
47. 47)
  - 4. Dumortier, H., Lacotte, S., Pastorin, G., et al: ‘Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells’, Nano Lett., 2006, 6, pp. 1522–1528 (doi: 10.1021/nl061160x).

Functionalisation of MWCNTs with piperazine and dopamine derivatives and their potential antibacterial activity

References

Related content